Mrs Amber Van Broekhoven

Radboud University Nijmegen, Nijmegen (Netherlands (The))

Follow

Contributor content

End-of-trial inflammatory biomarkers, lipid levels, creatine kinase and markers of renal and liver function in the LoDoCo2 trial.

Presentation

End-of-trial inflammatory biomarkers, lipid levels, creatine kinase and markers of renal and liver function in the LoDoCo2 trial.

ESC 365 is supported by

novartis

Explore sponsored resources